Foresite Capital Fund IV, L.P.
Insider CIK 1704131 · AERI 10% owner · ACRS 10% owner · KNTE 10% owner · EIKN 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 2,502,252 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 10,000,000 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 5,204,684 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 2,602,342 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 282,317 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 282,317 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 282,317 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 3,422,051 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 1,711,025 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 284,392 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 501,219 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 6,878 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 12,123 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion deriv | 2026-02-04 | 2026-02-06 | 3,048,192 | — | $0 | 0 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 335,521 | — | $0 | 1,676,399 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 408,725 | — | $0 | 408,725 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 38,133 | — | $0 | 425,852 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 922 | — | $0 | 387,719 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 37,855 | — | $0 | 386,797 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 348,942 | — | $0 | 348,942 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 458,855 | — | $0 | 1,263,428 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 67,207 | — | $0 | 804,573 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 1,626 | — | $0 | 737,366 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 37,855 | — | $0 | 735,740 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 697,885 | — | $0 | 697,885 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 229,428 | — | $0 | 1,943,682 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 37,855 | — | $0 | 1,714,254 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | P Buy | 2026-02-04 | 2026-02-06 | 55,555 | $18.00 | $1000.0K | 1,318,983 | SEC↗ |
| EIKN Eikon Therapeutics, Inc. | C Conversion | 2026-02-04 | 2026-02-06 | 1,340,878 | — | $0 | 1,340,878 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 9,671,643 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 520,711 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 3,525,957 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-08 | 2023-05-10 | 229,044 | $2.80 | $641.3K | 520,711 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-08 | 2023-05-10 | 1,550,956 | $2.80 | $4.34M | 3,525,957 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | J Other | 2023-02-17 | 2023-02-22 | 1,100,000 | — | $0 | 1,975,001 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2021-11-01 | 2021-11-03 | 8,276 | — | $0 | 8,276 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2021-11-01 | 2021-11-03 | 1,954,904 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 48,376 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 145,128 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 157,222 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 18,641 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 55,922 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 2,666,002 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 99,488 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 298,465 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 6,347,893 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 9,171,643 | — | $0 | 9,671,643 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 166,667 | — | $0 | 291,667 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 500,001 | — | $0 | 875,001 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2020-12-03 | 2020-12-04 | 125,000 | $20.00 | $2.50M | 125,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2020-12-03 | 2020-12-04 | 500,000 | $20.00 | $10.00M | 500,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2020-12-03 | 2020-12-04 | 375,000 | $20.00 | $7.50M | 375,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2020-02-27 | 2020-03-02 | 271,767 | $17.07 | $4.64M | 1,229,633 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2020-02-27 | 2020-03-02 | 302,776 | $17.07 | $5.17M | 1,369,938 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | S Sale | 2020-02-27 | 2020-03-02 | 425,457 | $17.07 | $7.26M | 1,925,020 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-12-20 | 2019-12-23 | 289 | — | $0 | 0 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-12-20 | 2019-12-23 | 28,900 | $30.00 | $867.0K | 1,501,400 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-12-03 | 2019-12-05 | 266 | — | $0 | 289 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-12-03 | 2019-12-05 | 26,600 | $30.00 | $798.0K | 1,472,500 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-11-26 | 2019-12-05 | 44 | — | $0 | 555 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-11-26 | 2019-12-05 | 4,400 | $30.00 | $132.0K | 1,445,900 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-11-15 | 2019-11-18 | 199 | — | $0 | 599 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-11-15 | 2019-11-18 | 19,900 | $30.00 | $597.0K | 1,441,500 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-11-14 | 2019-11-18 | 57 | — | $0 | 798 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-11-14 | 2019-11-18 | 5,700 | $30.00 | $171.0K | 1,421,600 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise deriv | 2019-11-07 | 2019-11-12 | 150 | — | $0 | 855 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | X Exercise | 2019-11-07 | 2019-11-12 | 15,000 | $30.00 | $450.0K | 1,415,900 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-09-05 | 2019-09-06 | 15,700 | $18.42 | $289.2K | 2,350,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-09-04 | 2019-09-06 | 9,300 | $18.48 | $171.9K | 2,334,777 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-09-04 | 2019-09-06 | 90,900 | $18.48 | $1.68M | 1,400,900 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-09-03 | 2019-09-04 | 15,100 | $21.45 | $323.9K | 2,325,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-09-03 | 2019-09-04 | 34,900 | $20.54 | $716.8K | 2,310,377 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-30 | 2019-09-04 | 25,000 | $21.36 | $534.0K | 2,275,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-23 | 2019-08-23 | 38,300 | $23.42 | $897.0K | 2,250,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-22 | 2019-08-23 | 6,700 | $23.68 | $158.7K | 2,212,177 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-21 | 2019-08-23 | 1,153 | $23.25 | $26.8K | 2,205,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-20 | 2019-08-20 | 50,000 | $23.21 | $1.16M | 2,204,324 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-19 | 2019-08-20 | 3,847 | $23.34 | $89.8K | 2,154,324 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-16 | 2019-08-20 | 100,000 | $24.23 | $2.42M | 2,150,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-14 | 2019-08-14 | 100,000 | $23.73 | $2.37M | 2,050,477 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-13 | 2019-08-14 | 71,097 | $24.92 | $1.77M | 1,131,097 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-13 | 2019-08-14 | 178,903 | $25.52 | $4.57M | 1,310,000 | SEC↗ |
| AERI AERIE PHARMACEUTICALS INC | P Buy | 2019-08-12 | 2019-08-14 | 189,555 | $24.43 | $4.63M | 1,060,000 | SEC↗ |